Tennessee Oncology-Chattanooga — Chattanooga, Tennessee

Tennessee Oncology-Chattanooga is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Tennessee Oncology-Chattanooga has participated in 4 clinical trials.

Therapeutic areas: Myelodysplastic Syndrome, MDS, Diffuse Large B-Cell Lymphoma.

Sponsors: Helsinn Healthcare SA, SCRI Development Innovations, LLC, Hutchmed.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology-Chattanooga?

Tennessee Oncology-Chattanooga has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology-Chattanooga conducted?

Tennessee Oncology-Chattanooga has 4 clinical trials on record. Their work covers Myelodysplastic Syndrome, MDS, Diffuse Large B-Cell Lymphoma.

Is Tennessee Oncology-Chattanooga accredited by Crixeo Health?

Tennessee Oncology-Chattanooga has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology-Chattanooga?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.